UBS raised the firm’s price target on Wix.com (WIX) to $255 from $250 and keeps a Buy rating on the shares. Wix’s fiscal 2024 were 1% above the high end of its initial bookings guide and in-line with the high end of its initial revenue guidance, the analyst tells investors in a research note. While it is hard to defend a back-half loaded top-line guide when the scope for margin expansion appears less promising vs. 2023-2024, UBS likes that Wix is assuming almost no contribution from new products in its FY25 guidance and is pushing to use AI in its care organization.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on WIX:
- Wix.com price target raised to $260 from $250 at Benchmark
- Wix.com price target lowered to $194 from $208 at Wells Fargo
- Wix.com price target raised to $280 from $275 at Citi
- Wix’s Strong Financial Performance and Future Growth Prospects Earn a ‘Buy’ Rating
- Wix.com price target raised to $240 from $236 at Barclays